Insider Trading & Ownership - COLUMN GROUP GP LP

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for COLUMN GROUP GP LP
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-04-05
Sale
2024-04-08
8:04 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
10% Owner
21,743,413$0$02,000
(Indirect
Direct)
View
2023-11-15
Purchase
2023-11-17
4:30 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
22,631$0.6852$15,50721,743,413
(Indirect
Direct)
View
2023-01-30
Purchase
2023-02-01
4:50 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
184,272$4.9986$921,11021,720,782
(Indirect
Direct)
View
2023-01-23
Purchase
2023-01-25
4:35 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
9,900$4.9994$49,49421,536,510
(Indirect
Direct)
View
2023-01-19
Purchase
2023-01-23
4:22 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
38,139$4.9976$190,60321,526,610
(Indirect
Direct)
View
2023-01-12
Purchase
2023-01-17
4:34 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
5,378$4.9466$26,60321,488,471
(Indirect
Direct)
View
2023-01-10
Purchase
2023-01-12
4:37 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
309,070$4.7865$1,479,35921,483,093
(Indirect
Direct)
View
2022-12-12
Purchase
2022-12-14
4:29 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
300$4.9767$1,49321,174,023
(Indirect
Direct)
View
2022-11-21
Purchase
2022-11-23
4:17 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
40,327$4.9988$201,58821,173,723
(Indirect
Direct)
View
2022-11-03
Purchase
2022-11-07
4:20 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
139,148$4.9187$684,42721,133,396
(Indirect
Direct)
View
2022-10-27
Purchase
2022-10-31
5:19 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
76,877$4.8602$373,63820,994,248
(Indirect
Direct)
View
2022-10-25
Purchase
2022-10-27
6:55 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Column Group Opportunity III LP
Column Group Opportunity III GP LP
Director
10% Owner
123,820$4.8088$595,42820,917,371
(Indirect
Direct)
View
2022-06-09
Purchase
2022-06-13
5:05 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
984,161$13.5$13,286,17418,143,374
(Indirect
Direct)
View
2022-06-02
Purchase
2022-06-06
4:44 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
34,200$13.03$445,73918,110,897
(Indirect
Direct)
View
2022-05-31
Purchase
2022-06-02
4:28 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
153,806$13.46$2,069,66718,109,768
(Indirect
Direct)
View
2022-05-26
Purchase
2022-05-31
5:02 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
22,911$13.49$309,03518,104,692
(Indirect
Direct)
View
2022-05-24
Purchase
2022-05-26
4:13 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
61,120$13.42$819,94818,103,936
(Indirect
Direct)
View
2022-05-19
Purchase
2022-05-23
4:14 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
39,700$13.36$530,45418,101,919
(Indirect
Direct)
View
2022-05-17
Purchase
2022-05-19
4:39 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
151,699$13.33$2,022,00418,100,609
(Indirect
Direct)
View
2022-05-13
Purchase
2022-05-17
4:22 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
162,531$2.6327$427,89118,095,603
(Indirect
Direct)
View
2022-05-11
Purchase
2022-05-13
5:32 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
166,350$11.43$1,902,03218,090,240
(Indirect
Direct)
View
2022-05-09
Purchase
2022-05-11
6:14 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
114,440$10.95$1,252,98218,084,750
(Indirect
Direct)
View
2022-01-24
Purchase
2022-01-26
7:14 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP III LP
COLUMN GROUP III-A LP
Column Group IV LP
Column Group IV-A LP
Column Group IV GP LP
TCG IV GP LLC
Director
10% Owner
849,701$0$018,080,973
(Indirect
Direct)
View
2021-02-17
Sale
2021-02-19
5:31 pm
CONSTELLATION PHARMACEUTICALS INCCNSTCOLUMN GROUP L P
COLUMN GROUP III LP
COLUMN GROUP III-A LP
COLUMN GROUP III GP LP
COLUMN GROUP GP LP
PONOI CAPITAL LP
Ponoi Management LLC
Ponoi Capital II LP
Ponoi II Management LLC
Kutzkey Tim
10% Owner
10,000$36.95$369,5036,230,638
(Indirect
Direct)
View
2020-09-01
Purchase
2020-09-03
5:31 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP II LP
Column Group II GP LP
Column Group Management LP
PONOI CAPITAL LP
Ponoi Management LLC
Ponoi Capital II LP
Ponoi II Management LLC
Kutzkey Tim
Director
10% Owner
64,089$17.65$1,131,35818,242,932
(Indirect
Direct)
View
2020-08-27
Purchase
2020-08-31
5:00 pm
NGM BIOPHARMACEUTICALS INCNGMCOLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP II LP
Column Group II GP LP
Column Group Management LP
PONOI CAPITAL LP
Ponoi Management LLC
Ponoi Capital II LP
Ponoi II Management LLC
Kutzkey Tim
Director
10% Owner
62,494$17.83$1,114,38218,178,843
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion